MedPath

M-SOLIFENACIN SUCCINATE

M-SOLIFENACIN SUCCINATE

Approved
DIN Number

02529696

Drug Class

Human

Market Date

Aug 18, 2023

Company
HC

mantra pharma inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02529696
AIG Number0151584001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
G04BD08 SOLIFENACIN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification86:12.04
Health Canada Classification

ACTIVE INGREDIENTS (1)

SOLIFENACIN SUCCINATEActive
Strength: 5 MG
Monograph: SOLIFENACIN SUCCINATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.